Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma
- 1 December 2005
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 163 (2) , 144-150
- https://doi.org/10.1016/j.cancergencyto.2005.06.023
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Drug resistance reversal—are we getting closer?European Journal Of Cancer, 2003
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Platinum‐based anticancer agents: Innovative design strategies and biological perspectivesMedicinal Research Reviews, 2003
- Mechanisms of resistance to cisplatinMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Epidemiological and molecular aspects of ovarian cancer riskZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancerEuropean Journal Of Cancer, 1999
- Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsGenes, Chromosomes and Cancer, 1997
- Epithelial ovarian carcinomaThe Lancet, 1997
- Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochemical Pharmacology, 1990